Ophthalmic manifestations in COVID-19-associated multiple mononeuropathy of the cranial nerves (clinical observation)

Close metadata

Recommended articles:

Efficacy and Safety of a New Selective Oral Factor Xa Inhibitor Amidine Hydrochloride for Prevention of Thromboembolic Events in Hospitalized Patients with COVID-19: a Multiple-Center Prospective Randomized Controlled Study. Journal of Venous Disorders. 2024;(2):154-162

A rare variant of thrombosis following a novel coronavirus infection. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):329-334

Cavitary lung lesions in COVID-19 associated pneumonia: a single-center study of 40 cases. Pirogov Russian Journal of Surgery. 2024;(6):28-35

Case of left ventricular wall aneurysm manifestation in patient with Marfan syndrome after SARS-CoV-2 re-infection. Russian Journal of Preventive Medicine. 2024;(6):88-90

Neurological complications in patients underwent COVID-19. Russian Journal of Preventive Medicine. 2024;(6):98-104

Method of comprehensive physiotherapy of dental patients after COVID-19. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):18-23

Comprehensive approach to rehabilitation of patients with COVID-19. (A literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(3):48-55

Risk factors for severe novel coronavirus infection SARS-CoV-2 in women during pregnancy. Russian Journal of Human Reproduction. 2024;(3):57-64

Results of detailed screening of patients who have undergone a novel coronavirus infection COVID-19. Russian Journal of Preventive Medicine. 2024;(7):16-22

A case of acute myocardial infarction of right ventricle with myomalacia and tamponade development after SARS-CoV-2 re-infection in the Loeys—Dietz syndrome patient. Russian Journal of Preventive Medicine. 2024;(7):73-76

Clinical manifestations of the new coronavirus infection can vary greatly and affect different organs and systems. Despite the lack of convincing data on the possible direct damage to the structures of the eyeball by the SARS-CoV-2 virus, indirect involvement of the organ of vision both in the acute period of the disease, during the period of convalescence, and as a part of the post-COVID syndrome is common in clinical practice. The condition of the ocular surface is not given much attention during the treatment of the main disease, especially in severe cases, which can lead to serious complications and visual acuity loss after recovery. Timely measures can prevent the loss of visual acuity. This article presents a description and discusses a rare case of multiple neuropathy of the cranial nerves associated with COVID-19, with bilateral involvement of the olfactory (I), trigeminal (V), facial (VII) and sublingual (XII) nerves, as well as the right optic nerve (II), which required staged rehabilitation.

Keywords:

lagophthalmos

keratopathy

facial palsy

COVID-19

SARS-CoV-2

multiple cranial nerves neuropathy

neurotrophic keratitis

Authors:

Grusha Y.O.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Krasnov Research Institute of Eye Diseases

ORCID: 0000-0002-6461-8243

Maksimova M.Yu.

Research Center of Neurology

Fettser E.I.

Krasnov Research Institute of Eye Diseases;
Sechenov First Moscow State Medical University

ORCID: 0000-0002-3729-7480

Received:

22.01.2022

Accepted:

04.05.2022

List of references:

Huang C, Wang Y, Li X, Ren L, Zhao J. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
Tyurin IE, Strutynskaya AD. Imaging of lung pathology in COVID-19 (literature review and own data). Pulmonologiya. 2020;30(5):658-670. (In Russ.). https://doi.org/10.18093/0869-0189-2020-30-5-658-670
Kabbani N, Olds JL. Does COVID19 infect the brain? If so, smokers might be at a higher risk. Mol Pharmacol. 2020;97(5):351-353. https://doi.org/10.1124/molpharm.120.000014
Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020;(9):1764-1773. https://doi.org/10.1111/ene.14277
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. NeurologicManifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6):683-690. https://doi.org/10.1001/jamaneurol.2020.1127
Matías-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. Should we expect neurological symptoms in the SARS-CoV-2 epidemic? Neurologia. 2020;35(3):170-175. https://doi.org/10.1016/j.nrl.2020.03.001
Paterson RW, Brown RL, Benjamin L, at al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143(10):3104-3120. https://doi.org/10.1093/brain/awaa240
Valiuddin HM, Kalajdzic A, Rosati J, Boehm K, Hill D. Update on Neurological Manifestations of SARS-CoV-2. West J Emerg Med. 2020;21(6):45-51. https://doi.org/10.5811/westjem.2020.8.48839
Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020;41(11):3039-3056. https://doi.org/10.1007/s10072-020-04708-8
Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, O’Hana Nobleza C, Azarpazhooh MR, Catanese L, Elicer I, Jafari M, Liberati F, Camejo C, Torbey M, Divani AA. Peripheral Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9. https://doi.org/10.1007/s11910-021-01102-5
Vasanthapuram VH, Badakere A. Internuclear ophthalmoplegia as a presenting feature in a COVID-19-positive patient. BMJ Case Rep. 2021;14(4): e241873. https://doi.org/10.1136/bcr-2021-241873
Tisdale AK, Chwalisz BK. Neuro-ophthalmic manifestations of coronavirus disease 19. Curr Opin Ophthalmol. 2020;31(6):489-494. https://doi.org/10.1097/ICU.0000000000000707
Murchison AP, Sweid A, Dharia R, Theofanis TN, Tjoumakaris SI, Jabbour PM, Bilyk JR. Monocular visual loss as the presenting symptom of COVID-19 infection. Clin Neurol Neurosurg. 2021;201:106440. https://doi.org/10.1016/j.clineuro.2020.106440
Luís ME, Hipólito-Fernandes D, Mota C, Maleita D, Xavier C, Maio T, Cunha JP, Tavares Ferreira J. A Review of Neuro-Ophthalmological Manifestations of Human Coronavirus Infection. Eye Brain. 2020;12:129-137. https://doi.org/10.2147/EB.S268828
Marchenko NR, Kasparova EA, Budnikova EA, Makarova MA. Anterior eye segment damage in coronavirus infection (COVID-19). The Russian Annals of Ophthalmology = Vestnik oftal’mologii. 2021;137(6):142-148. (In Russ.). https://doi.org/10.17116/oftalma2021137061142
Yusef YuN, Kazaryan EE, Andzhelova DV, Vorobyova MV. Ophthalmological manifestations of post-COVID-19 syndrome. The Russian Annals of Ophthalmology = Vestnik oftal’mologii. 2021;137(5-2):331-339. (In Russ.). https://doi.org/10.17116/oftalma2021137052331
Kurysheva NI. COVID-19 i porazhenie organa zreniya [COVID-19 and eye damage]. M.: Largo; 2021;79. (In Russ.).
Yachou Y, El Idrissi A, Belapasov V, AitBenali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10): 2657-2669. https://doi.org/10.1007/s10072-020-04575-3
Gholami M, Safari S, Ulloa L, Motaghinejad M. Neuropathies and neurological dysfunction induced by coronaviruses. J Neurovirol. 2021;27(3):380-396. https://doi.org/10.1007/s13365-021-00977-x
Finsterer J, Scorza FA, Scorza C, Fiorini A. COVID-19 associated cranial nerve neuropathy: A systematic review. Bosn J Basic Med Sci. 2021;22(1):39-45. https://doi.org/10.17305/bjbms.2021.6341
Laurendon T, Radulesco T, Mugnier J, Gérault M, Chagnaud C, El Ahmadi AA, Varoquaux A. Bilateral transient olfactory bulb edema during COVID-19-related anosmia. Neurology. 2020;95(5):224-225. https://doi.org/10.1212/WNL.0000000000009850
Grusha YO, Fedorov AA, Fettser EI. Paraliticheskij lagoftal’m [Paralytic lagophthalmos]. M.: GEOTAR-Media; 2019;224. (In Russ.).
Tan M, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25:352-355. https://doi.org/10.1097/01.ico.0000176609.42838.df24
Kandemirli SG, Altundag A, Yildirim D, Tekcan Sanli DE, Saatci O. Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia. Acad Radiol. 2021;28(1):28-35. https://doi.org/10.1016/j.acra.2020.10.006
Politi SL, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020;77(8):1028-1029. https://doi.org/10.1001/jamaneurol.2020.2125
Bilinska K, von Bartheld CS, Butowt R. Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19. Front Cell Neurosci. 2021;15:674123. https://doi.org/10.3389/fncel.2021.674123
Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020;417:117085. https://doi.org/10.1016/j.jns.2020.117085
You L, Kruse FE, Völcker HE. Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci. 2000;41:692-702.
Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci. 2000;41:1063-1069.

Close metadata